| [1] |
TIAN Ye, HE Quan, WANG Xiaojuan.
RPRD1B is highly expressed in human ovarian cancer cell lines and promotes tumor cell proliferation
[J]. Basic & Clinical Medicine, 2025, 45(8): 1066-1072.
|
| [2] |
ZHANG Yanchi, SHI Junqi, ZHANG Yijun, DUAN Jiawen, LIU Jinyu, ZHANG Liyan, LIANG Wanping.
Advances in synergistic therapies targeting metabolic mechanisms and the immune microenvironment in breast cancer
[J]. Basic & Clinical Medicine, 2025, 45(12): 1662-1667.
|
| [3] |
SHEN Hongmei, YU Yan, FENG Xuqiang, WANG Keqiang.
Usnea acid inhibits the proliferation of human ovarian cancer cell line
[J]. Basic & Clinical Medicine, 2025, 45(1): 31-37.
|
| [4] |
WU Yuhong, YU Caiyuan, YE Shicai.
Research progress on the role of NMES1 gene in malignant tumors
[J]. Basic & Clinical Medicine, 2024, 44(3): 403-407.
|
| [5] |
HUANG Jie, LI Runbo, GUO Jianxin, HAN Jian.
Expression of DDX5 and DDX17 in ovarian cancer tissues and their effects on proliferation and drug resistance of human ovarian cancer cell line SKOV3
[J]. Basic & Clinical Medicine, 2023, 43(8): 1247-1253.
|
| [6] |
ZHANG Yuxin, ZHU Ziwei, ZHANG Yan, HU Yuhong.
Effects of kaempferol regulating VPS9D1-AS1/miR-377-3p on proliferation and apoptosis of cervical cancer cell line SiHa
[J]. Basic & Clinical Medicine, 2023, 43(7): 1069-1078.
|
| [7] |
LENG Haina, ZHANG Yan, WANG Xiaodong, ZHANG Xueyou, LI Hongli.
miR-767-5p inhibits the invasion of ovarian cancer cell lines by regulating the expression of TBL1XR1 protein
[J]. Basic & Clinical Medicine, 2023, 43(3): 408-414.
|
| [8] |
TAN Shufen, YANG Xielan, YANG Linlin, LI Shuqing.
Effects of paclitaxel combined with carboplatin on expression of VEGF and tumor markers in ovarian cancer
[J]. Basic & Clinical Medicine, 2023, 43(12): 1861-1865.
|
| [9] |
WANG Juan, ZHANG Xiao-yan, ZHU Ai-hua, YU Hong-bo, FAN Xin-dan, TANG Chun-hui, YAO Xiu-fang.
High expression of Ku70 promotes proliferation of ovarian cancer cell lines and is associated with a poor prognosis for patients
[J]. Basic & Clinical Medicine, 2022, 42(9): 1391-1399.
|
| [10] |
HAN Tian-tian, YIN Jie, ZENG Jing, JIN Ying, LI Yan, PAN Ling-ya.
Establishment and identification of an ovarian cancer cell strain stably expressing CDC50A
[J]. Basic & Clinical Medicine, 2022, 42(6): 896-901.
|
| [11] |
YIN Jie, PAN Ling-ya, WEN Yi-ping, HUANG Hong, ZENG Jing, LI Xiao-ying, HAN Tian-tian, JIN Ying, LI Yan.
Identification of bio-functions of cancer stem-like cells and differentially expressed membrane proteins in side population cells from human epithelial ovarian cancer cell lines
[J]. Basic & Clinical Medicine, 2022, 42(2): 221-227.
|
| [12] |
DONG Hui, WANG Ting-ting, MA Xiao-hong, MA Sheng-zong, DING Yong-hui.
Screening of differential lncRNAs and expression analysis of lncRNA ZEB2-AS1 in ovarian cancer tissues
[J]. Basic & Clinical Medicine, 2022, 42(11): 1675-1680.
|
| [13] |
LIU Lian-ling, LI Yong.
Down-regulation of perilipin 2 inhibits proliferation of human gastric cancer cell line NCI-N87
[J]. Basic & Clinical Medicine, 2021, 41(7): 1013-1017.
|
| [14] |
DONG Ling-ling, GAO Yun, NIU Guo-yu.
Connective tissue growth factor promotes the proliferation and migration of human ovarian cancer cell line SKOV3
[J]. Basic & Clinical Medicine, 2021, 41(2): 193-196.
|
| [15] |
LI Shao-ru, QIN Hai-xia, LIU Shan-shan, HOU Rui-jie.
miR-493-5p inhibits the proliferation and migration of human ovarian cancer cell line SKOV3
[J]. Basic & Clinical Medicine, 2021, 41(12): 1749-1755.
|